US FDA issues Form 483 to Lupin’s Goa plant
The company has received seven observations from the US health regulator
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin launches authorised generic version of Duexis in US
Ibuprofen and Famotidine tablets, 800 mg/26.6 mg, are indicated for the relief of signs and symptoms of rheumatoid arthritis and…
Redefining job roles to build competitive compliance
Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a…
TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid
Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories, including many…
Lupin launches Luforbec 100/6 μg pMDI
It is the first branded generic alternative to Fostair 100/6 μg pMDI for the treatment of asthma and COPD in the UK
Lupin receives tentative US FDA approval for Brivaracetam tablets
The product will be manufactured at Lupin’s Nagpur facility in India
Lupin launches Tavaborole Topical Solution in US
It is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or…
Lupin gets tentative US FDA nod for Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (TLD)…
TLD is recommended by WHO, USAID and PEPFAR as a preferred first-line treatment regimen for the treatment of HIV in adults and…
Lupin gets US FDA approval for Sevelamer Hydrochloride Tablets
They are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis
Lupin gets warning letter from US FDA for Somerset facility
The US FDA had inspected the Lupin Somerset site from September 10, 2020, to November 5, 2020